| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Exelixis, Inc. (EXEL) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. EXEL is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.96M | $100.89M | - | |
| Dir | 1.55M | $79.76M | - | |
| Dir | 1.19M | $61.07M | - | |
| CFO | 1.12M | $57.37M | - | |
| VP | 594.7K | $30.54M | -43,451 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 29, 2022 | Hessekiel Jeffrey54 | EVP, General Counsel &Sec | Sell | 18,000 | $22.00 | $396,000.00 | -1.4% | +1.0% | -12.7% | |
| Mar 1, 2022 | Garber Alan M50 | Director | Sale+OE | 21,301 | $21.00 | $447,321.00 | -40.4% | -12.3% | -16.4% | |
| Feb 25, 2022 | Haley Patrick J.56 | EVP, Commercial | Sell | 31,238 | $19.53 | $610,078.14 | -13.6% | -9.9% | -15.1% | |
| Feb 24, 2022 | Hessekiel Jeffrey54 | EVP And General Counsel | Sell | 18,000 | $20.00 | $360,000.00 | -3.1% | -11.4% | -14.8% | |
| Feb 22, 2022 | Feldbaum Carl B47 | Director | Sale+OE | 20,000 | $19.49 | $389,800.00 | -70.1% | -9.4% | -11.4% | |
| Feb 22, 2022 | Papadopoulos Stelios53 | Director | Sell | 84,515 | $19.56 | $1,653,113.40 | -6.5% | -9.4% | -11.4% | |
| Feb 3, 2022 | Haley Patrick J.56 | EVP, Commercial | Sale+OE | 60,000 | $17.91 | $1,074,600.00 | -19.7% | +27.2% | -2.2% | |
| Dec 15, 2021 | Lamb Peter63 | EVP, Scientific Strategy &CSO | Sale+OE | 47,500 | $17.44 | $828,400.00 | -11.6% | +13.7% | -11.5% | |
| Nov 24, 2021 | Haley Patrick J.56 | EVP, Commercial | Sell | 17,236 | $17.25 | $297,321.00 | -6.8% | +12.1% | -3.1% | |
| Nov 19, 2021 | Feldbaum Carl B47 | Director | Sale+OE | 20,000 | $17.62 | $352,400.00 | -70.1% | +1.7% | -6.2% |